We read with great interest the article by Spiezia et al, published in a recent issue of the
journal, showing a severe hypercoagulability on thromboelastometry profiles of 22 critically …

Coronavirus disease 2019 (COVID-19) is associated with an increased risk of thrombotic
complications. 1 Multiple lines of evidence support the existence of a hypercoagulable state …

The pathophysiology of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has puzzled the medical community …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory virus that
can cause severe illness (COVID-19) in infected individuals. Infected individuals with severe …

We read with much interest the recent observational study of Nougier et al, which aimed at
studying thrombin generation (TG) and fibrinolysis profiles of coronavirus disease 2019 …

Patients critically ill with COVID-19 are at risk for thrombotic events despite prophylactic
anticoagulation. Impaired fibrinolysis has been proposed as an underlying mechanism. Our …

We are grateful for the comments of Marrietta et al. 1 and welcome the opportunity to provide
further details on the coagulopathy observed in our patients with coronavirus disease 2019 …

Dear Editor, We read with interest the study published by Tang et al1 in a recent issue of the
Journal of Thrombosis and Haemostasis. In this retrospective analysis, conducted at the …

Coronavirus-2019 (COVID-19) infection is responsible for the pandemic outbreak across the
world. The pathophysiology of COVID-19 has been characterized by endothelial …

Tang et al recently reported that, in COVID-19 infections caused by the novel coronavirus
(SARS-CoV-2), heparin anticoagulant therapy lowers the mortality rate in patients who …